by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Genetic: CAR 70-BCMA CAR-T; Drug: Fludarabine and Cyclophosphamide Sponsors: The General Hospital of Western Theater Command Not yet recruiting Conditions: Relapsed or Refractory Plasma Cell...
by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Hematologic Neoplasms; Oncologic Disorders Interventions: Other: LLM-Generated Plain-Language Patient Synopsis Sponsors: Technical University of Munich Not yet recruiting Conditions: Hematologic Neoplasms; Oncologic Disorders Interventions: Other:...
by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Sepsis; Mortality; Biomarkers Sponsors: Antalya Training and Research Hospital Completed Conditions: Sepsis; Mortality; Biomarkers Sponsors: Antalya Training and Research Hospital Completed
by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Cardiac Arrest (CA) Interventions: Behavioral: T-CPR; Behavioral: AED-optimized T-CPR Sponsors: University of Pecs Recruiting Conditions: Cardiac Arrest (CA) Interventions: Behavioral: T-CPR; Behavioral: AED-optimized T-CPR Sponsors: University of Pecs...
by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Shoulder Anterior Latarjet Instability Interventions: Procedure: Open coracoid impingement repair without capsuloplasty; Procedure: Open coracoid impingement repair with capsuloplasty Sponsors: Clinique du Sport, Bordeaux Mérignac Not yet...
by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials
Conditions: Atrial Fibrillation Interventions: Drug: Metoprolol succinate; Drug: Amiodarone Sponsors: Shanghai East Hospital Not yet recruiting Conditions: Atrial Fibrillation Interventions: Drug: Metoprolol succinate; Drug: Amiodarone Sponsors: Shanghai East...